225 related articles for article (PubMed ID: 10803790)
1. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cyanamide and disulfiram in effects on liver function.
Tamai H; Yokoyama A; Okuyama K; Takahashi H; Maruyama K; Suzuki Y; Ishii H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):97S-99S. PubMed ID: 10803789
[TBL] [Abstract][Full Text] [Related]
3. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
[TBL] [Abstract][Full Text] [Related]
4. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
Bruguera M; Lamar C; Bernet M; Rodés J
Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
[TBL] [Abstract][Full Text] [Related]
5. Cyanamide hepatotoxicity. Incidence and clinico-pathological features.
Bruguera M; Parés A; Heredia D; Rodés J
Liver; 1987 Aug; 7(4):216-22. PubMed ID: 3683093
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis induced by drugs used as alcohol aversion therapy.
Vázquez JJ; Diaz de Otazu R; Guillen FJ; Zozaya J; Pardo FJ
Diagn Histopathol; 1983; 6(1):29-37. PubMed ID: 6307616
[TBL] [Abstract][Full Text] [Related]
7. Cyanamide-induced liver injury. A predictable lesion.
Vazquez JJ; Guillen FJ; Zozaya J; Lahoz M
Liver; 1983 Aug; 3(4):225-30. PubMed ID: 6323909
[TBL] [Abstract][Full Text] [Related]
8. Structural hepatic changes associated with cyanamide treatment: cholangiolar proliferation, fibrosis and cirrhosis.
Moreno A; Vazquez JJ; Ruizdel Arbol L; Guillen FJ; Colina F
Liver; 1984 Feb; 4(1):15-21. PubMed ID: 6321877
[TBL] [Abstract][Full Text] [Related]
9. [Hepatotoxicity induced by cyanamide. A review of the anatomicopathological changes apropos a case].
Román Llorente FJ; Iglesias García E; Fojón Polanco S; Mariño Callejo A; Pia Iglesias G; Gordo Fraile P
An Med Interna; 1989 Nov; 6(11):589-90. PubMed ID: 2562702
[TBL] [Abstract][Full Text] [Related]
10. [Cyanamide-ethanol reaction induced shock: report of a case and literature review].
Kondo Y; Fuke C; Higa A; Kukita I
Chudoku Kenkyu; 2013 Dec; 26(4):295-9. PubMed ID: 24483008
[TBL] [Abstract][Full Text] [Related]
11. Co-existence of hepatocyte ground-glass inclusions from several causes.
Alonso-Marti C; Moreno A; Barat A; Solera JC; Oliva H
Histopathology; 1990 Mar; 16(3):304-7. PubMed ID: 2158937
[TBL] [Abstract][Full Text] [Related]
12. Cyanamide-induced liver cell injury. Experimental study in the rat.
Guillen FJ; Vazquez JJ
Lab Invest; 1984 Apr; 50(4):385-93. PubMed ID: 6323849
[TBL] [Abstract][Full Text] [Related]
13. Ethanol patch test: a simple method for identifying the effectiveness of cyanamide in alcoholics.
Yamauchi M; Kimura T; Takeda K; Sakamoto K; Ohata M; Tabe T; Nakano K; Fujiwara S; Takao Y; Toda G
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):39S-42S. PubMed ID: 10803778
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyanamide and placebo in the treatment of alcohol dependence of adolescents.
Niederhofer H; Staffen W; Mair A
Alcohol Alcohol; 2003; 38(1):50-3. PubMed ID: 12554608
[TBL] [Abstract][Full Text] [Related]
15. Ground-glass hepatocellular inclusions are associated with polypharmacy.
Lu HC; González IA; Byrnes K
Ann Diagn Pathol; 2021 Jun; 52():151740. PubMed ID: 33836412
[TBL] [Abstract][Full Text] [Related]
16. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide.
Hashimoto K; Hoshii Y; Takahashi M; Mitsuno S; Hanai N; Watanabe Y; Ishihara T
Histopathology; 2001 Jul; 39(1):60-5. PubMed ID: 11454045
[TBL] [Abstract][Full Text] [Related]
17. [Agranulocytosis related to calcium cyanamide (Colme)].
Morales Lázaro A; Sánchez Blanco JJ; Funes Vera C; Sanz Imedio E
Sangre (Barc); 1990 Oct; 35(5):412. PubMed ID: 2291154
[No Abstract] [Full Text] [Related]
18. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.
Nonomura A; Mizukami Y; Unoura M; Kobayashi K; Takeda Y; Takeda R
Gastroenterol Jpn; 1992 Aug; 27(4):521-8. PubMed ID: 1526433
[TBL] [Abstract][Full Text] [Related]
19. Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.
Buechler C; Schäffler A; Johann M; Neumeier M; Köhl P; Weiss T; Wodarz N; Kiefer P; Hellerbrand C
J Gastroenterol Hepatol; 2009 Apr; 24(4):558-63. PubMed ID: 19067777
[TBL] [Abstract][Full Text] [Related]
20. Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan).
Thomsen P; Reinicke V
Liver; 1981 Mar; 1(1):67-73. PubMed ID: 6294436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
